Enable job alerts via email!
A groundbreaking biotech company, Mytos, seeks a hardware engineer to enhance their automated human cell production systems. The role involves designing robust components, improving reliability, and refining machine features. Candidates should bring experience in complex product development, particularly in lab automation or medical devices, and enjoy working collaboratively in a fast-paced environment.
About Us
You rarely get the chance to change an entire industry. But that's the position we find ourselves in. Join us, and you’ll unleash scientists, accelerate their research and help get cures to patients sooner.
We’ve developed machines to fully automate human cell production - the most manual process in Biotech. Cells are used to discover and develop new drugs, and now they're being used to cure diseases like Parkinson’s and age-related blindness. Mytos will impact cure development across the board.
We're live in multibillion dollar biotechs on both coasts of the US, and raised $19m to expand into the market faster, and accelerate our development! Next year, neurons grown on our machines will be going into Parkinson patient brains.
We’ve assembled a world-class team to take on this challenge, with ex-Dyson engineers and Nature-published scientists working hand-in-hand. You can learn more about your potential Mytos teammates here: Team
Mytos is backed by Y Combinator, the most successful startup program in the world which produced companies such as AirBnb, Dropbox, and Ginkgo Bioworks.
This is an opportunity to work on projects at the interface of engineering and biology. When you join us, you’ll get to:We’re building a team that enjoys moving fast and not killing cells, strives for continuous improvement through learning from mistakes and is passionate about work that contributes to solving real world problems.
We get excited about meeting potential colleagues from broad scientific/engineering backgrounds and who share our enthusiasm for unconstrained innovation and understanding our users.